1. Scrip
  2. >>Focus On Asia

No More Big Fish In A Small Pond: Yuhan Opts For Globalization For Long-Term Growth

 
• By Jung Won Shin

After clinching massive licensing-out agreements with multinationals last year, Yuhan is setting out a long-term global road map with a determination that it won’t just remain top in the South Korean market. The head of the firm's newly established global strategy department talks to Scrip how and why it aims to achieve globalization in the next decade and beyond.

Skyscraper
Yuhan At Inflection Point As Centenary Nears • Source: Shutterstock

Yuhan Corp. is entering a new phase in its nearly 100-year history. While it has largely been generating revenues in the domestic market, it is now betting its future on pursuing globalization, which will include bringing in advanced technologies and seeking clinical development and commercialization in overseas.

“Yuhan is the number one pharma in South Korea, but globally, it is not even included in the top 100

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

More from Focus On Asia